Saroja Pharma Industries India Limited IPO : Company Info.

Saroja Pharma Industries India Limited IPO is set to launch on 31 August, 2023. The company initiated its business operations in the year 2019. It exports, trades and supplies Chemicals and API. The product portfolio of the company includes Pharma Intermediary, Chemical and Veterinary Pharma API. It supplies products like Liquid bromine which is a necessary product for many segments. Its exports are done to various countries like Egypt, Pakistan, Jordan, Russia, Singapore, Hong Kong etc. 

Saroja Pharma Industries India Limited IPO DETAILS

Saroja Pharma Industries India Limited IPO is set to launch on 31 August, 2023. The subscription timeline extends till 5 September, 2023. The size for the IPO is 9.11 Crore Rs. Shares issued through fresh issue mode are worth 9.11 Crore Rs. No Shares are issued through offer for sale mode. The lot size is 1600 shares and the price is 84 Rs per share. The company is going to get listed at NSE SME. The face value per share is Rs.10 and this is a Fixed Price issue. The registrar for the company is KFin Technologies Limited.

Tabular Description of Saroja Pharma Industries India Limited IPO 

Saroja Pharma Industries India Limited IPO : IMPORTANT DATES

Saroja Pharma Industries India Limited IPO begins for subscription from 31 August, 2023. The IPO subscription would continue till 5 September, 2023. The allotment status for the shareholders who applied would come on 8 September, 2023. The refunds for the ones who did not get allotment would be initiated on 11 September, 2023. The DEMAT accounts of shareholders would be credited on 12 September, 2023. The listing of the company would be completed on 13 September, 2023.

Saroja Pharma Industries India Limited IPO : Lead Managers

The lead managers are :

• Swastika Investments Limited

The minimum lot size for the company is decided at 1600 shares. This holding accounts to 134000 Rs.. The maximum lot size is decided at 3200 shares (HNI). This amounts to 268000 Rs.. Hence the company’s final holdings would be set as :

OBJECTIVES FOR THE IPO

• IPO proceeds would be used for general corporate purposes.
• The company will use the IPO money for further working capital requirements.
• The borrowings of the company will also be paid off with the IPO money 
• IPO money will be used for expansion purposes as well.

COMPANY FINANCIALS

Saroja Pharma Industries India Limited had an asset base of 822 Lakh Rs in the year 2021. This increased to 1551 Lakh Rs in the year 2022 and 2133 Lakh Rs in the year 2023. The revenue of the firm was 3674 Lakh Rs in 2021. The revenue boosted to 5595 Lakh Rs in 2022. However in 2023 the same came down to 5035 Lakh Rs. The company’s profit was 73 Lakh Rs in 2021. This increased to 114 Lakh Rs in 2022. However the profits also came down to 106 Lakh Rs in 2023 as seen in the revenue figures of the same year. Hence the figures of 2023 are not as good as the ones in 2022.

PROS

• The product portfolio of the company includes Pharma Intermediary, Chemical and Veterinary Pharma API. It supplies products like Liquid bromine which is a necessary product for many segments. 
• Its exports are done to various countries like Egypt, Pakistan, Jordan, Russia, Singapore, Hong Kong etc. 

CONS

• The company works in a highly competitive segment.

Saroja Pharma Industries India Limited IPO Application Process with Zerodha

It is very easy to apply for an IPO now if you have a DEMAT account with Zerodha. Follow the steps below for the same :

1.   Logging into Zerodha console through its website or KITE platform. Clicking the IPO section present in the ORDER tab.
2.   Click the Saroja Pharma Industries India Limited IPO button and press the BID button.
3.   Entering the details asked for like UPI ID, Quantity and price.
4.   Submit the application form for the IPO.
5. Visiting the application of UPI for approving the transaction.

Now, applying for an IPO online is possible with most of the Discount and online brokers.